Jones Jeffrey Alan 4

What Happened

• Jeffrey Alan Jones, Chief Medical Officer of Cullinan Therapeutics (CGEM), sold 4,982 shares on Feb 20, 2026. The shares were disposed at $13.62 each for a total of $67,855. This was a sale (routine liquidity/tax-related) rather than a purchase.

Key Details

• Transaction date: 2026-02-20
• Price per share: $13.62; Shares sold: 4,982; Total proceeds: $67,855
• Transaction type reported: Sale (code S), described as "open market or private sale"
• Footnote: Sale made to cover personal income tax obligations upon vesting of restricted stock units (RSUs)
• Shares owned after transaction: Not specified in the provided filing
• Filing date: 2026-02-23 (filed within the typical 2-business-day Form 4 reporting window)

Context

• The filing indicates the sale was to satisfy tax withholding on RSU vesting — a common, non-investment-motivated reason for insiders to sell shares. Such tax-withholding sales are generally considered routine and do not necessarily signal a change in the insider’s view of the company.